Yasin Keshvargar
Lawyers
Filters
Precigen $79 million preferred stock and warrants offering
We advised Precigen on the private placement
Ormat Technologies $282 million secondary offering
The stock is listed on the NYSE and Tel Aviv Stock Exchange
Sabre $800 million exchange offer and $775 million term loan exchange
We are advising Sabre on the exchange offers
Enviva emerges from chapter 11
We advised an ad hoc group of creditors in connection with Enviva’s chapter 11 proceedings
Spirit Airlines prearranged chapter 11 filing
We are advising Spirit Airlines in connection with entry into an RSA and negotiation of a prearranged chapter 11 plan
Molecular Partners $20 million follow-on offering
The ADSs are listed on the Nasdaq Global Select Market
Inventiva private placement of up to €348 million
The offering includes ordinary shares, pre-funded warrants and warrants
Immatics $150 million follow-on offering
We advised Immatics on the offering of shares
Labcorp $2 billion senior notes offering
The investment-grade notes are due 2030, 2032 and 2034
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering